Loading...
XNYSENOV
Market cap2.50bUSD
Jan 10, Last price  
44.77USD
1D
-2.21%
1Q
11.31%
Jan 2017
24.60%
IPO
118.39%
Name

Enovis Corp

Chart & Performance

D1W1MN
XNYS:ENOV chart
P/E
P/S
1.47
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
6.23%
Rev. gr., 5y
-14.18%
Revenues
1.71b
+9.22%
309,653,000345,478,000393,604,000506,305,000604,854,000525,024,000541,987,000693,392,0003,913,856,0004,207,209,0004,624,476,0003,967,053,0003,647,047,0003,300,184,0003,666,812,0003,327,458,0003,070,769,0003,854,303,0001,563,101,0001,707,197,000
Net income
-33m
L-12.90%
57,306,00012,247,00094,00064,882,000-571,00021,722,00016,215,0004,555,000-64,402,000178,628,000392,098,000167,739,000128,111,000151,090,000140,196,00018,863,00064,082,00098,693,000-38,189,000-33,261,000
CFO
135m
P
-7,754,000-17,355,00074,483,000-31,513,00038,286,00061,965,00057,153,000164,299,000362,169,000385,758,000303,813,000246,974,000218,770,000226,367,000130,948,000301,935,000356,099,000-55,861,000134,988,000
Earnings
Feb 20, 2025

Profile

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
IPO date
May 08, 2008
Employees
16,200
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,707,197
9.22%
1,563,101
-59.45%
Cost of revenue
791,749
754,545
Unusual Expense (Income)
NOPBT
915,448
808,556
NOPBT Margin
53.62%
51.73%
Operating Taxes
(13,289)
36,120
Tax Rate
4.47%
NOPAT
928,737
772,436
Net income
(33,261)
-12.90%
(38,189)
-138.69%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,776
5,814
BB yield
-0.06%
-0.20%
Debt
Debt current
21,568
219,279
Long-term debt
585,100
142,518
Deferred revenue
Other long-term liabilities
204,178
166,989
Net debt
570,477
321,002
Cash flow
Cash from operating activities
134,988
(55,861)
CAPEX
(122,223)
(105,450)
Cash from investing activities
(242,467)
(176,388)
Cash from financing activities
127,797
(465,127)
FCF
767,640
1,268,829
Balance
Cash
36,191
24,295
Long term investments
16,500
Excess cash
Stockholders' equity
519,954
524,072
Invested Capital
4,161,295
3,913,652
ROIC
23.00%
13.76%
ROCE
22.00%
20.66%
EV
Common stock shares outstanding
54,495
54,065
Price
56.02
4.67%
53.52
16.42%
Market cap
3,052,800
5.50%
2,893,581
23.08%
EV
3,625,586
3,216,299
EBITDA
1,132,548
1,028,266
EV/EBITDA
3.20
3.13
Interest
19,749
24,052
Interest/NOPBT
2.16%
2.97%